Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Voting Common Shares, no par value
-
Shares outstanding
-
51.9M
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
6.73M
-
Shares change
-
+1.15M
-
Total reported value, excl. options
-
$36.5M
-
Value change
-
+$6.25M
-
Put/Call ratio
-
0.02
-
Number of buys
-
26
-
Number of sells
-
-10
-
Price
-
$5.43
Significant Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) as of Q4 2024
52 filings reported holding DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value as of Q4 2024.
DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.73M shares
of 51.9M outstanding shares and own 12.97% of the company stock.
Largest 10 shareholders include COOPERMAN LEON G (1.63M shares), VANGUARD GROUP INC (1.24M shares), FIRST MANHATTAN CO. LLC. (839K shares), PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE (515K shares), Bleichroeder LP (382K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (375K shares), GEODE CAPITAL MANAGEMENT, LLC (306K shares), NORTHERN TRUST CORP (180K shares), LPL Financial LLC (152K shares), and BlackRock, Inc. (108K shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.